These arent just theoretical conceptstheyre on the horizon
Only when Eli Lilly began testing dual GLP-1/GIP agonists did the picture change dramatically
Were excited to see how our customers succeed as more innovative treatments become available. The company is also introducing a new membership for weight loss, which will include comprehensive support services, 24/7 direct access to providers, personalized nutrition guidance, ongoing clinical check-ins, as well as peer support in the Hers Weight Loss community
Scientists have long recognised the potential benefits of transdermal drug delivery, including improved patient compliance, steady drug release, and avoidance of gastrointestinal degradation and first-pass metabolism
Were passing that access and value along to our customers, who deserve the highest standard of clinical safety and efficacy to meet their goals, and we're doing it in a safe, affordable way that others cant deliver." According to the US Food and Drug Administration (FDA), around 70% of American adults have obesity or are overweight, and losing 5 to 10% of that body weight can reduce weight-related health risks, such as diabetes and cardiovascular disease
The same medications can also create practical side-effect questions